Literature DB >> 12426232

Atypical pathogen infection in adults with acute exacerbation of bronchial asthma.

David Lieberman1, Devora Lieberman, Shmuel Printz, Miriam Ben-Yaakov, Zilia Lazarovich, Bella Ohana, Maureen G Friedman, Bella Dvoskin, Maija Leinonen, Ida Boldur.   

Abstract

In a serologically based prospective study, acute infections with four atypical pathogens were determined in 100 adults hospitalized for acute exacerbation of bronchial asthma, and compared with the corresponding rate in a matched control group. Paired sera were tested using immunofluorescence or enzyme immunoassay methods to establish the serologic diagnosis. In 18 patients (18%), there was evidence of acute infection with Mycoplasma pneumoniae, compared with 3% in the control group (p = 0.0006). In 10 of these patients there was evidence of infection with at least one additional pathogen, a respiratory virus in 7. There was no significant difference between the study groups in the rates of acute infection by Chlamydia pneumoniae (8% in the hospitalized patients versus 6% in the control subjects), Legionella spp. (5 versus 3%, respectively), or Coxiella burnettii (no patients in either group). We conclude that of these four atypical pathogens, only infection with M. pneumoniae is associated with hospitalization for acute exacerbation of bronchial asthma. In most of these M. pneumoniae patients there is evidence of infection with a respiratory virus as well. The pathophysiologic and therapeutic significance of these findings should be tested in further studies specifically designed to address these questions.

Entities:  

Mesh:

Year:  2002        PMID: 12426232     DOI: 10.1164/rccm.200209-996OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  44 in total

1.  Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.

Authors:  Jorge L Medina; Jacqueline J Coalson; Edward G Brooks; Vicki T Winter; Adriana Chaparro; Molly F R Principe; Thirumalai R Kannan; Joel B Baseman; Peter H Dube
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

2.  Etanercept in chronic severe asthma.

Authors:  C Oliveri; R Polosa
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

Review 3.  Asthma exacerbations. 2: aetiology.

Authors:  A M Singh; W W Busse
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

Review 4.  Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia.

Authors:  Lokesh Sharma; Ashley Losier; Thomas Tolbert; Charles S Dela Cruz; Chad R Marion
Journal:  Clin Chest Med       Date:  2016-12-24       Impact factor: 2.878

5.  Mast cells protect against airway Mycoplasma pneumoniae under allergic conditions.

Authors:  N M Michels; H W Chu; S C LaFasto; S R Case; M N Minor; R J Martin
Journal:  Clin Exp Allergy       Date:  2010-03-23       Impact factor: 5.018

Review 6.  Infection in severe asthma exacerbations and critical asthma syndrome.

Authors:  Christian E Sandrock; Andrew Norris
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

7.  Atypical bacteria and macrolides in asthma.

Authors:  Paraskevi Xepapadaki; Ioanna Koutsoumpari; Vasiliki Papaevagelou; Christina Karagianni; Nikolaos G Papadopoulos
Journal:  Allergy Asthma Clin Immunol       Date:  2008-09-15       Impact factor: 3.406

8.  Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease.

Authors:  Seoung-Ju Park; Yong-Chul Lee; Yang-Keun Rhee; Heung-Bum Lee
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

9.  Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin.

Authors:  R Doug Hardy; Jacqueline J Coalson; Jay Peters; Adriana Chaparro; Chonnamet Techasaensiri; Angelene M Cantwell; T R Kannan; Joel B Baseman; Peter H Dube
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

Review 10.  Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype.

Authors:  R H Dougherty; J V Fahy
Journal:  Clin Exp Allergy       Date:  2009-02       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.